BioCentury | Jan 12, 2021
Product Development

OX40L pipeline: Data Byte

...ovarian cancer patients.DNAtrix Inc. is investigating an adenovirus engineered to express OX40L, while Sichuan Clover Biopharmaceuticals Inc. and Shattuck Labs Inc....
...TNF) receptor superfamily member 4 OX40L (CD134L) – OX40 ligand Danielle Golovin KY1005 MRNA-2416 mRNA-2752 SL-279252, TAK-252 ISB 830 Kymab Group Ltd. Moderna Inc. DNAtrix Inc. Shattuck Labs Inc. Takeda...
BioCentury | Nov 13, 2020
Translation in Brief

Roche and Immune-Onc mAb data; plus Capricor’s exosome-based COVID-19 vaccine induces cellular immunity, and more

...signs of efficacyAt this week’s SITC meeting, Shattuck Labs Inc....
...Inc. Johns Hopkins University Public Health England Oxford Immunotec Ltd. Stanford University Shattuck Labs Inc. ImCheck...
BioCentury | Oct 9, 2020
Finance

Data Bytes: the year of the mega-IPO

...$250 million in its NASDAQ listing, while Shattuck Labs Inc....
BioCentury | Oct 9, 2020
Finance

Kronos’ post-IPO gains build on $1B+ postmoney valuation

...$8.07 to $27.07.Posting more modest gains were Shattuck Labs Inc....
...Signal regulatory protein alpha Paul Bonanos Spruce Biosciences Inc. Shattuck Labs Inc. Kronos...
BioCentury | Jun 16, 2020
Finance

June 15 Quick Takes: RA makes $200M investment in Novavax; plus venture rounds for Shattuck, ImmVira, Glyscend and Shukun

...company gained $5.50 (12%) to $51.07 Monday. Crossover investors in $118M series B for Shattuck Shattuck Labs Inc....
...previous investors China Creation Ventures and Huagai Capital. Targets TNF - Tumor necrosis factor BioCentury Staff NVX-CoV2373 NanoFlu Novavax Inc. Shattuck Labs Inc. ImmVira...
BioCentury | Dec 11, 2019
Company News

Management tracks: Elevate hires CSO of regenerative medicine; plus BridgeBio, Acceleron, Flexion, Locana, Nkarta and more

...Hesterlee was EVP of portfolio development and head of neuromuscular programs at Asklepios BioPharmaceutical Inc. Shattuck Labs Inc....
BioCentury | Jan 20, 2017
Company News

Heat, Shattuck deal

...financial terms. Heat Biologics Inc. (NASDAQ:HTBX), Durham, N.C. Shattuck Labs Inc., Austin, Texas Business: Cancer Chris Lieu Heat Biologics Inc. Shattuck Labs Inc....
Items per page:
1 - 7 of 7
BioCentury | Jan 12, 2021
Product Development

OX40L pipeline: Data Byte

...ovarian cancer patients.DNAtrix Inc. is investigating an adenovirus engineered to express OX40L, while Sichuan Clover Biopharmaceuticals Inc. and Shattuck Labs Inc....
...TNF) receptor superfamily member 4 OX40L (CD134L) – OX40 ligand Danielle Golovin KY1005 MRNA-2416 mRNA-2752 SL-279252, TAK-252 ISB 830 Kymab Group Ltd. Moderna Inc. DNAtrix Inc. Shattuck Labs Inc. Takeda...
BioCentury | Nov 13, 2020
Translation in Brief

Roche and Immune-Onc mAb data; plus Capricor’s exosome-based COVID-19 vaccine induces cellular immunity, and more

...signs of efficacyAt this week’s SITC meeting, Shattuck Labs Inc....
...Inc. Johns Hopkins University Public Health England Oxford Immunotec Ltd. Stanford University Shattuck Labs Inc. ImCheck...
BioCentury | Oct 9, 2020
Finance

Data Bytes: the year of the mega-IPO

...$250 million in its NASDAQ listing, while Shattuck Labs Inc....
BioCentury | Oct 9, 2020
Finance

Kronos’ post-IPO gains build on $1B+ postmoney valuation

...$8.07 to $27.07.Posting more modest gains were Shattuck Labs Inc....
...Signal regulatory protein alpha Paul Bonanos Spruce Biosciences Inc. Shattuck Labs Inc. Kronos...
BioCentury | Jun 16, 2020
Finance

June 15 Quick Takes: RA makes $200M investment in Novavax; plus venture rounds for Shattuck, ImmVira, Glyscend and Shukun

...company gained $5.50 (12%) to $51.07 Monday. Crossover investors in $118M series B for Shattuck Shattuck Labs Inc....
...previous investors China Creation Ventures and Huagai Capital. Targets TNF - Tumor necrosis factor BioCentury Staff NVX-CoV2373 NanoFlu Novavax Inc. Shattuck Labs Inc. ImmVira...
BioCentury | Dec 11, 2019
Company News

Management tracks: Elevate hires CSO of regenerative medicine; plus BridgeBio, Acceleron, Flexion, Locana, Nkarta and more

...Hesterlee was EVP of portfolio development and head of neuromuscular programs at Asklepios BioPharmaceutical Inc. Shattuck Labs Inc....
BioCentury | Jan 20, 2017
Company News

Heat, Shattuck deal

...financial terms. Heat Biologics Inc. (NASDAQ:HTBX), Durham, N.C. Shattuck Labs Inc., Austin, Texas Business: Cancer Chris Lieu Heat Biologics Inc. Shattuck Labs Inc....
Items per page:
1 - 7 of 7